Skip to main content

Table 1 Patient characteristic

From: State diagrams of the heart – a new approach to describing cardiac mechanics

Subject

Age

Gender

HR

Clinical features

Medications

NSTEMI

49

male

65

Hypertension, hyperlipidemia

ASA, Clopidogrel, betablocker, statin, calcium antagonist

NSTEMI

53

male

70

Smoker, hypertension, hyperlipidemia

ASA, ACE1, Clopidogrel, betablocker, statin, calcium antagonist, diuretics

NSTEMI

55

female

63

Smoker, psoriasis

ASA, Clopidogrel, betablocker, statin

NSTEMI

56

male

61

Smoker

ASA, Clopidogrel, betablocker, statin

NSTEMI

60

male

59

Renal failure

ASA, Clopidogrel, statin,

NSTEMI

63

male

56

Smoker, hypertension

ASA, Clopidogrel, betablocker, statin, ACE-inhibitor,

NSTEMI

72

male

53

Diabetes II

ASA, Clopidogrel, betablocker, statin, ACE-inhibitor, Metforminen, Glibenclamide

Control

49

male

60

Ex-smoker, hypertension, diabetes II

ASA, ACE1, betablocker, calcium antagonist, metformine

Control

52

male

59

Myeloma

Talidomide, steroids, ASA

Control

54

female

57

Diabetes II, Bypass 2004

Statin, betablocker, calcium antagonist, metformine

Control

59

male

71

Hypertension, liver cirrosis

-

Control

62

male

66

Ex-smoker, hypothyreosis

Levaxine

Control

62

male

70

Atrial fibrillation

Betablocker

Control

73

male

54

-

-

  1. Patient characteristic for the NSTEMI group and their matched controls.